Demichelis; Francesca

Patent Applications and Registrations

Patent applications and USPTO patent grants for Demichelis; Francesca.The latest application filed is for "spectral imaging for measurement of nuclear pathology features in cancer cells prepared for in situ analysis".

Company Profile

0.18.16

Demichelis; Francesca - New York NY
Demichelis; Francesca - Cambridge MA
Demichelis; Francesca - Turin IT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Image acquisition methods for simultaneously detecting genetic rearrangement and nuclear morphology Grant 11,441,189 - Demichelis , et al. September 13, 2	2022-09-13
Recurrent gene fusions in prostate cancer Grant 10,190,173 - Tomlins , et al. Ja	2019-01-29
Spectral Imaging For Measurement Of Nuclear Pathology Features In Cancer Cells Prepared For In Situ Analysis App 20180291464 - Demichelis; Francesca ; et al.	2018-10-11
Spectral imaging for measurement of nuclear pathology features in cancer cells prepared for in situ analysis Grant 9,951,388 - Demichelis , et al. April 24, 2	2018-04-24
Recurrent gene fusions in prostate cancer Grant 9,745,635 - Tomlins , et al. August 29, 2	2017-08-29
ERG/TFF3/HMWCK triple immunostain for detection of prostate cancer Grant 9,678,077 - Rubin , et al. June 13, 2	2017-06-13
Recurrent Gene Fusions In Prostate Cancer App 20160319369 - Tomlins; Scott ; et al.	2016-11-03
Recurrent Gene Fusions In Prostate Cancer App 20160097104 - Tomlins; Scott ; et al.	2016-04-07
Recurrent gene fusions in prostate cancer Grant 9,284,609 - Tomlins , et al. March 15, 2	2016-03-15
Spectral Imaging for Measurement of Nuclear Pathology Features in Cancer Cells Prepared for In Situ Analysis App 20150197811 - Demichelis; Francesca ; et al.	2015-07-16
Erg/tff3/hmwck Triple Immunostain For Detection Of Prostate Cancer App 20150132767 - Rubin; Mark A. ; et al.	2015-05-14
Recurrent gene fusions in prostate cancer Grant 8,969,527 - Tomlins , et al. March 3, 2	2015-03-03
Spectral Imaging for Measurement of Nuclear Pathology Features in Cancer Cells Prepared for In Situ Analysis App 20140296088 - Demichelis; Francesca ; et al.	2014-10-02
Recurrent gene fusions in prostate cancer Grant 8,580,509 - Tomlins , et al. November 12, 2	2013-11-12
Recurrent Gene Fusions In Prostate Cancer App 20130040858 - Tomlins; Scott ; et al.	2013-02-14
Recurrent Gene Fusions In Prostate Cancer App 20120295809 - Tomlins; Scott ; et al.	2012-11-22
Recurrent Gene Fusions In Prostate Cancer App 20120296070 - Tomlins; Scott ; et al.	2012-11-22
Recurrent gene fusions in prostate cancer Grant 8,211,645 - Tomlins , et al. July 3, 2	2012-07-03
Methods for identifying and using SNP panels Grant 7,981,609 - Rubin , et al. July 19, 2	2011-07-19
Recurrent Gene Fusions In Prostate Cancer App 20110034677 - Tomlins; Scott ; et al.	2011-02-10
Biomarkers for predicting prostate cancer progression Grant 7,803,552 - Rubin , et al. September 28, 2	2010-09-28
Biomarkers For Predicting Prostate Cancer Progression App 20100137164 - Rubin; Mark A. ; et al.	2010-06-03
Recurrent gene fusions in prostate cancer Grant 7,718,369 - Tomlins , et al. May 18, 2	2010-05-18
Biomarkers for predicting prostate cancer progression Grant 7,666,595 - Rubin , et al. February 23, 2	2010-02-23
Methods for identifying and using SNP panels App 20090004652 - Rubin; Mark A. ; et al.	2009-01-01
Biomarkers for predicting prostate cancer progression App 20060234259 - Rubin; Mark A. ; et al.	2006-10-19
Thermophotovoltaic converter Grant 4,331,829 - Palazzetti , et al. May 25, 1	1982-05-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.